# US 2021/0332152 A1 · Peptide fusion protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332152 A1
- Document ID: US20210332152A1
- Status: Published application
- Kind: A1
- Application number: 17/264,577
- Filed: 2019-08-01
- Published: 2021-10-28
- Earliest claimed: 2018-08-01
- Assignees: Kagoshima University; Daicel Corporation
- Applicants: Kagoshima University; Daicel Corporation
- Inventors: Yuji ITO; Seiichi UCHIMURA; Hiromichi OKURA
- Web page: https://patentgrep.com/patent/US20210332152A1

## CPC

- C07K 19/00: Hybrid peptides {, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes}
- C07K 1/22: Affinity chromatography or related techniques based upon selective absorption processes
- C07K 7/06: having 5 to 11 amino acids
- C07K 7/08: having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68)
- C07K 14/43595: {from coelenteratae, e.g. medusae}
- C07K 17/00: Carrier-bound or immobilised peptides (carrier-bound or immobilised enzymes C12N11/00); Preparation thereof
- C07K 2319/30: Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

An object of the present invention is to provide a method by which a peptide having a specific binding capability that can be used for purification of a target molecule can be produced at a low cost, and specifically relates to a peptide fusion protein including one or more peptides having specific binding capability and a scaffold protein, the peptide being inserted into the amino acid sequence of the scaffold protein directly or via a peptide linker, and/or being linked to the N-terminal and/or C-terminal of the scaffold protein.

## Claims

### Claim 1

A peptide fusion protein comprising one or more peptides having a specific binding capability and a scaffold protein, the peptide being inserted into an amino acid sequence of the scaffold protein directly or via a peptide linker, and/or being linked to an N-terminal and/or C-terminal of the scaffold protein.

### Claim 2 (depends on 1)

The peptide fusion protein according to claim 1, wherein the peptide having a specific binding capability is an antibody-binding peptide.

### Claim 3 (depends on 2)

The peptide fusion protein according to claim 2, wherein the antibody-binding peptide is selected from the group consisting of an IgG-binding peptide, an IgA-binding peptide, and an IgY-binding peptide.

### Claim 4 (depends on 3)

The peptide fusion protein according to claim 3, wherein the IgG-binding peptide is a peptide having a cyclic structure.

### Claim 5 (depends on 1)

The peptide fusion protein according to claim 1, comprising two or more of the peptides.

### Claim 6 (depends on 1)

The peptide fusion protein according to claim 1, wherein the scaffold protein is a protein having a β-barrel structure.

### Claim 7 (depends on 6)

The peptide fusion protein according to claim 6, wherein the protein having a β-barrel structure is green fluorescent protein (GFP), red fluorescent protein (DsRed), or a variant thereof.

### Claim 8 (depends on 7)

The peptide fusion protein according to claim 7, wherein the GFP variant is Superfolder GFP or Superfolder yellow fluorescent protein (YFP).

### Claim 9 (depends on 1)

The peptide fusion protein according to claim 1, wherein the peptide linker comprises one or more amino acid sequences: GGGGS (SEQ ID NO: 35).

### Claim 10 (depends on 1)

The peptide fusion protein according to claim 1, wherein the peptide linker is linked to the N-terminal and/or C-terminal of the peptide.

### Claim 11 (depends on 1)

A solid-phase carrier having the peptide fusion protein described in claim 1 immobilized thereon.

### Claim 12 (depends on 11)

The solid-phase carrier according to claim 11, which has a spacer between the peptide fusion protein and a solid phase.

### Claim 13 (depends on 11)

A column for separating a target molecule, comprising the solid-phase carrier described in claim 11.

### Claim 14 (depends on 1)

A method for producing a peptide fusion protein, comprising culturing a cell having a nucleic acid encoding the peptide fusion protein described in claim 1.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the cell is Escherichia coli.
